Balance Sheet Data

BioMarin Pharmaceutical Inc. (BMRN)

$87.56

+0.42 (+0.48%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 753.811,065.391,013.871,291.541,073.811,388.311,517.991,659.781,814.821,984.34
Total Cash (%)
Account Receivables 377.40448.35373.40461.32633.70606.67663.34725.30793.05867.13
Account Receivables (%)
Inventories 680.27698.55776.67894.081,107.181,100.181,202.941,315.311,438.171,572.50
Inventories (%)
Accounts Payable 570.62191.43193231.24683.15494.65540.86591.38646.61707.01
Accounts Payable (%)
Capital Expenditure -163.41-137.52-119.22-131.54-107.61-180.73-197.61-216.07-236.26-258.32
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.